Clonidine Hydrochloride NDC 72162-1367

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-1367Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-1367Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72162-1367-6	72162136706	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-1367-6)Marketed from Jul 16, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clonidine Hydrochloride
Generic name (nonproprietary): clonidine hydrochloride
Active ingredients: Clonidine hydrochloride — .1 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209757
Marketing start: Feb 15, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha2-Agonists (Mechanism)
Identifiers: Product ID 72162-1367_2c7b0581-f1a8-45ae-97ea-8cb4bf6b7403SPL ID 2c7b0581-f1a8-45ae-97ea-8cb4bf6b7403SPL set ID 36bd0f0e-5569-466a-ab1b-90eb39efdd68RxCUI 1013930UNII W76I6XXF06
Pharmacologic class: Central alpha-2 Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162136706 followed by a unit qualifier and the quantity

Package 72162-1367-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 16, 2024.

Indications (excerpt from the label)

Clonidine hydrochloride extended-release tablets is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14) ]. Clonidine hydrochloride extended-release tablets is a centrally acting alpha2-adrenergic agonist indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209757

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209757
Product	Strength	Form · route	Labeler	Product NDC
Clonidine Hydrochloride	Clonidine hydrochloride .1 mg/1	Tablet, Extended releaseOral	Solco Healthcare LLC	43547-435
Clonidine Hydrochloride	Clonidine hydrochloride .1 mg/1	Tablet, Extended releaseOral	Xiamen LP Pharmaceutical Co., Ltd.	71034-001